Advertisement

Topics

Gyros Protein Technologies Introduces New ADA Solution for Immunogenicity Market

09:25 EDT 29 Jun 2017 | Businesswire
This article has expired, however you can still download the PDF.
Preview:
Developed to support assay development and validation for detection of anti-drug antibodies Gyros Protein Technologies AB, a pioneer in automated nanoliter-scale immunoassays and leading provider of peptide synthesizers and ...

Other Sources for this Article

Media:
Zyme Communications
Katie Odgaard
Tel: +44(0)7787 502 947
Email: katie.odgaard@zymecommunications.com

NEXT ARTICLE

More From BioPortfolio on "Gyros Protein Technologies Introduces New ADA Solution for Immunogenicity Market"

Quick Search
Advertisement
 

Relevant Topics

Assays
An assay is an analytic procedure for qualitatively assessing or quantitatively measuring the presence or amount or the functional activity of a target entity.  This can be a drug or biochemical substance or a cell in an organism or organic sample. ...

Pharmacy
Pharmacy is the science and technique of preparing as well as dispensing drugs and medicines. It is a health profession that links health sciences with chemical sciences and aims to ensure the safe and effective use of pharmaceutical drugs. The scope of...

Antibodies
An antibody is a protein produced by the body's immune system when it detects harmful substances, called antigens. Examples of antigens include microorganisms (such as bacteria, fungi, parasites, and viruses) and chemicals. Antibodies may be produc...